| 名稱 | UGT1A1*28 Reference Standard |
| 型號 | CBPA0016 |
| 報價 |  |
| 特點 | UGT1A1*28 Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- CYP2C9基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP1A1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- VKORC1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- MTHFR基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2D6基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2C19基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 新品發(fā)布【地中海貧血標(biāo)準(zhǔn)品】
- 耳聾基因檢測標(biāo)準(zhǔn)品
- 研究發(fā)現(xiàn)氣候可能決定人的鼻子形狀
- 細(xì)胞株的核型分析實驗操作流程分析
聯(lián)系我們
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > 用藥指導(dǎo) > CBPA0016UGT1A1*28 Reference Standard
- 詳細(xì)內(nèi)容
| CBPA0016 | |
| Format | Genomic DNA |
| Description | UGT1A1, UDP-glucuronosyltransferase 1-1, is an enzyme that catalyzes the glucuronidation of substances to soluble metabolites for excretion (PMID: 28520360). Genetic polymorphisms in UGT1A1 may alter the metabolism of chemotherapy drugs such as irinotecan, resulting in severe toxicity. |
| Technical Data | |
| Gene | UGT1A1 |
| AA Change | N/A |
| DNA Change | N/A |
| Chr position (GRCh38) | NC_000002.12_g.233760233_233760234insTA |
| Allelic Frequency | 50% |
| Zygosity | Heterozygous |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4°C |
| Expiry | 36 months from the date of manufacture |
